缺氧时肝癌HepG2细胞HIF-1α对GLUT-1表达的影响及机制探讨

被引:4
作者
梁辉 [1 ]
宫伟 [2 ]
姬宏斌 [1 ]
赵威 [3 ]
张琳娜 [4 ]
康洪林 [1 ]
机构
[1] 解放军第医院肿瘤外科
[2] 解放军第医院骨科
[3] 第四军医大学西京医院急诊科
[4] 宁夏医科大学基础学院生理学教研室
关键词
肝肿瘤; 氧缺乏; 缺氧诱导因子1α; 葡萄糖转运蛋白1; 肿瘤细胞,培养的;
D O I
10.13267/j.cnki.syzlzz.2013.03.019
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
目的探讨缺氧状态下肝癌HepG2细胞中HIF-1α表达对GLUT-1的影响。方法 HepG2人肝癌细胞株,以DMEM培养基加胎牛血清培养,分为常氧对照组(21%O2),缺氧组(1%O2),常氧加吲哚美辛组,缺氧加吲哚美辛组。收获细胞后,分别行免疫荧光法检测细胞内HIF-1α的表达和核转位;Western blot检测各组的HIF-1α、GLUT-1蛋白表达;RT-PCR检测各组的GLUT-1mRNA含量。结果缺氧时HIF-1α(蛋白:68.25±11.72)和GLUT-1(mRNA:0.7424±0.1127;蛋白:70.33±12.83)在肝癌HepG2细胞中的表达增高(P<0.05);缺氧时以吲哚美辛抑制HIF-1α蛋白(36.34±9.50)稳定和积聚后,GLUT-1 mRNA(0.3710±0.1016)及蛋白(38.46±12.20)表达受到抑制(P<0.05)。结论缺氧可以上调HIF-1α和GLUT-1在肝癌HepG2细胞中的表达;HIF-1α可以调控其下游靶基因GLUT-1的转录和表达,影响糖酵解和细胞能量的产生。
引用
收藏
页码:265 / 269
页数:5
相关论文
共 6 条
[1]  
Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells[J]. Tian-Qi Liu,Jun Fan,Lin Zhou and Shu-Sen Zheng Key Laboratory of Combined Multi-organ Trans-plantation,Ministry of Public Health;Key Laboratory of Organ Trans-plantation,Zhejiang Province;and Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery;State Key Laboratory for Diagnosis and Treatment of Infectious Disease,First Affiliated Hospital,
[2]   严重烧伤大鼠肝脏葡萄糖转运体1蛋白表达的实验研究 [J].
戚华兵 ;
王凤君 ;
汪仕良 .
第三军医大学学报, 2003, (18) :1613-1616
[3]   The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer [J].
Rajaganeshan, R. ;
Prasad, R. ;
Guillou, P. J. ;
Poston, G. ;
Scott, N. ;
Jayne, D. G. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (11) :1049-1055
[4]  
Hypoxia in cancer: significance and impact on clinical outcome[J] . Peter Vaupel,Arnulf Mayer. Cancer and Metastasis Reviews . 2007 (2)
[5]   2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF [J].
Mabjeesh, NJ ;
Escuin, D ;
LaVallee, TM ;
Pribluda, VS ;
Swartz, GM ;
Johnson, MS ;
Willard, MT ;
Zhong, H ;
Simons, JW ;
Giannakakou, P .
CANCER CELL, 2003, 3 (04) :363-375
[6]  
HIF-1 and tumor progression: pathophysiology and therapeutics[J] . Gregg L. Semenza. Trends in Molecular Medicine . 2002 (4)